National recommendations for the management of rhinitis
DOI:
https://doi.org/10.6016/ZdravVestn.3526Keywords:
clinical decision-making, allergy, sinusitis, nasal polyps, allergen immunotherapyAbstract
The article presents the recommendations for managing patients with rhinitis in Slovenia. It covers the treatment of allergic and non-allergic rhinitis, as well as rhinosinusitis with or without nasal polyps. It also addresses allergy management, the use of allergen immunotherapy, and its effect on symptom reduction. The national recommendations are based on international guidelines and offer a comprehensive overview of pharmacological and non-pharmacological treatment options for these conditions. The article emphasizes the importance of clinical decision-making, patient and healthcare provider collaboration at all levels, and regular monitoring. The recommendations aim to support professionals at all levels in providing evidence-based care for patients with rhinitis and related conditions.
Downloads
References
1. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al.; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-76.
DOI: 10.1016/j.jaci.2010.06.047
PMID: 20816182
2. Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6(1):47.
DOI: 10.1186/s13601-016-0137-4
PMID: 28050247
3. Lourenço O, Bosnic-Anticevich S, Costa E, Fonseca JA, Menditto E, Cvetkovski B, et al. Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice. Pharmacy (Basel). 2020;8(2):85.
DOI: 10.3390/pharmacy8020085
PMID: 32429362
4. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58:1-464.
DOI: 10.4193/Rhin20.401
PMID: 32077450
5. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765-98.
DOI: 10.1111/all.13317
PMID: 28940458
6. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657-65.
DOI: 10.1111/all.13200
PMID: 28474799
7. Kreft S, Razinger B. Assessment report on Echinacea purpurea (L.) Moench, adix. Amsterdam: European medicines agency; 2021.
8. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1).
DOI: 10.1183/13993003.01136-2019
PMID: 31515408
9. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657-65.
DOI: 10.1111/all.13200
PMID: 28474799
10. Bosnic‐Anticevich S, Costa E, Menditto E, Lourenço O, Novellino E, Bialek S, et al. ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy". Allergy. 2019;74(7):1219-36.
DOI: 10.1111/all.13701
PMID: 30565275
11. Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, et al. International consensus statement on allergy and rhinology: allergic rhinitis - 2023. Int Forum Allergy Rhinol. 2023;13(4):293-859.
DOI: 10.1002/alr.23090
PMID: 36878860
12. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines — 2016 revision. J Allergy Clin Immunol. 2016;140(4):950-8.
DOI: 10.1016/j.jaci.2017.03.050
PMID: 28602936
13. Sierocinski E, Holzinger F, Chenot JF. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol. 2021;77(8):1113-22.
DOI: 10.1007/s00228-021-03090-4
PMID: 33523253
14. Chang GH, Yang PR, Cheng YC, Hsu KH, Wu CY, Yang YH, et al. Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway - an in vitro and in clinic study. BMC Complement Med Ther. 2022;22(1):313.
DOI: 10.1186/s12906-022-03791-y
PMID: 36447209
15. Sierocinski E, Holzinger F, Chenot JF. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol. 2021;77(8):1113-22.
DOI: 10.1007/s00228-021-03090-4
PMID: 33523253
16. Zidarn M, Bajrović N, Jenko K, Kopač P, Košnik M, Edelbaher N, et al. Aria 2016 executive summary: integrated care pathways for predictive medicine across the life cycle. Zdrav Vestn. 2019;88(5–6):291-301.
DOI: 10.6016/ZdravVestn.2702
17. May JR, Dolen WK. Management of Allergic Rhinitis: A Review for the Community Pharmacist. Clin Ther. 2017;39(12):2410-9.
DOI: 10.1016/j.clinthera.2017.10.006
PMID: 29079387
18. Zidarn M. Sensitization to inhalant alergens in patients with allegic airway disease in Slovenia. Zdrav Vestn. 2013;82(6):378.
19. Bousquet PJ, Hooper R, Kogevinas M, Jarvis D, Burney P, Chinn S, et al. Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I. Clin Exp Allergy. 2007;37(5):780-7.
DOI: 10.1111/j.1365-2222.2007.02714.x
PMID: 17456226
20. Rondón C, Campo P, Togias A, Fokkens WJ, Durham SR, Powe DG, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460-7.
DOI: 10.1016/j.jaci.2012.02.032
PMID: 22516477
21. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765-98.
DOI: 10.1111/all.13317
PMID: 28940458
22. Bousquet J, Anto JM, Demoly P, Schünemann HJ, Togias A, Akdis M, et al.; WHO Collaborating Center for Asthma and Rhinitis. Severe chronic allergic (and related) diseases: a uniform approach—a MeDALL—GA2LEN—ARIA position paper. Allergy Rhinol (Providence). 2013;4(2):e94-9.
DOI: 10.2500/ar.2013.4.0051
PMID: 24124643
23. Armengot M, Garćia-Lliberós A, Gómez MJ, Navarro A, Martorell A. Sinonasal involvement in systemic vasculitides and cocaine-induced midline destructive lesions: Diagnostic controversies. Allergy Rhinol (providence). 2013;4(2):e94-9.
DOI: 10.2500/ar.2013.4.0051
PMID: 24124643
24. Mainz JG, Koitschev A. Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asthma Rep. 2012;12(2):163-74.
DOI: 10.1007/s11882-012-0250-y
PMID: 30623897
25. Lucas JS, Barbato A, Collins SA, Goutaki M, Behan L, Caudri D, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017;49(1):1601090.
DOI: 10.1183/13993003.01090-2016
26. Wojciechowska J, Kręcicki T. Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis. Acta Otorhinolaryngol Ital. 2018;38(6):517-27.
DOI: 10.14639/0392-100X-1776
27. Scadding GK, Smith PK, Blaiss M, Roberts G, Hellings PW, Gevaert P, et al. Allergic Rhinitis in Childhood and the New EUFOREA Algorithm. Front Allergy. 2021;2:706589.
DOI: 10.3389/falgy.2021.706589
PMID: 35387065
28. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63:8-160.
DOI: 10.1111/j.1398-9995.2007.01620.x
PMID: 18331513
29. Evcimik MF, Dogru M, Cirik AA, Nepesov MI. Adenoid hypertrophy in children with allergic disease and influential factors. Int J Pediatr Otorhinolaryngol. 2015;79(5):694-7.
DOI: 10.1016/j.ijporl.2015.02.017
PMID: 25758194
30. Calderon MA, Gerth van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, et al.; European Academy of Allergy and Clinical Immunology. Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol. 2012;23(4):300-6.
DOI: 10.1111/j.1399-3038.2012.01313.x
PMID: 22594930
31. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007. ;62(8)-8.
DOI: 10.1111/j.1398-9995.2007.01451.x
PMID: 17620073
32. Muraro A, Halken S, Arshad SH, Beyer K, Dubois AE, Du Toit G, et al. EAACI Food Allergy and Anaphylaxis Guidelines. 2021. ;32(5)-58.
DOI: 10.1111/pai.13496
PMID: 33710678
33. Saulyte J, Regueira C, Montes-Martínez A, Khudyakov P, Takkouche B. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med. 2014;11(3):e1001611.
DOI: 10.1371/journal.pmed.1001611
PMID: 24618794
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Slovenian Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
